Aarkstore - Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore - Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014

Description:

“Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014”, provides an overview of the Idiopathic Pulmonary Fibrosiss therapeutic pipeline. For more details : – PowerPoint PPT presentation

Number of Views:31

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014


1
Aarkstore - Idiopathic Pulmonary Fibrosis -
Pipeline Review, H2 2014
www.aarkstore.com
2
Summary
  • Idiopathic Pulmonary Fibrosis - Pipeline Review,
    H2 2014, provides an overview of
  • the Idiopathic Pulmonary Fibrosiss therapeutic
    pipeline.
  • This Market Research Report provides
    comprehensive information on the therapeutic
  • development for Idiopathic Pulmonary Fibrosis,
    complete with comparative analysis at
  • various stages, therapeutics assessment by drug
    target, mechanism of action (MoA), route of
  • administration (RoA) and molecule type, along
    with latest updates, and featured news and
  • press releases. It also reviews key players
    involved in the therapeutic development for
  • Idiopathic Pulmonary Fibrosis and special
    features on late-stage and discontinued
    projects.

www.aarkstore.com
www.aarkstore.com
3
Scope
  • - The report provides a snapshot of the
    global therapeutic landscape of Idiopathic
    Pulmonary Fibrosis- The report reviews key
    pipeline products under drug profile section
    which includes, product description, MoA and RD
    brief, licensing and collaboration details
    other developmental activities - The report
    reviews key players involved in the therapeutics
    development for Idiopathic Pulmonary Fibrosis and
    enlists all their major and minor projects- The
    report summarizes all the dormant and
    discontinued pipeline projects - A review of the
    Idiopathic Pulmonary Fibrosis products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources- Pipeline
    products coverage based on various stages of
    development ranging from pre-registration till
    discovery and undisclosed stages- A detailed
    assessment of monotherapy and combination therapy
    pipeline projects- Coverage of the Idiopathic
    Pulmonary Fibrosis pipeline on the basis of
    target, MoA, route of administration and molecule
    type

www.aarkstore.com
4
Reasons to buy
  • - Provides strategically significant
    competitor information, analysis, and insights to
    formulate effective RD development strategies-
    Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive
    advantage- Develop strategic initiatives by
    understanding the focus areas of leading
    companies- Identify and understand important and
    diverse types of therapeutics under development
    for Idiopathic Pulmonary Fibrosis- Plan mergers
    and acquisitions effectively by identifying key
    players of the most promising pipeline- Devise
    corrective measures for pipeline projects by
    understanding Idiopathic Pulmonary Fibrosis
    pipeline depth and focus of Indication
    therapeutics- Develop and design in-licensing
    and out-licensing strategies by identifying
    prospective partners with the most attractive
    projects to enhance and expand business potential
    and Scope- Modify the therapeutic portfolio by
    identifying discontinued projects and
    understanding the factors that drove them from
    pipeline  

www.aarkstore.com
5
Table of Contents
  • IntroductionREPORT COVERAGEIdiopathic
    Pulmonary Fibrosis OverviewTherapeutics
    DevelopmentPipeline Products for Idiopathic
    Pulmonary Fibrosis - OverviewPipeline Products
    for Idiopathic Pulmonary Fibrosis - Comparative
    AnalysisIdiopathic Pulmonary Fibrosis -
    Therapeutics under Development by
    CompaniesIdiopathic Pulmonary Fibrosis -
    Therapeutics under Investigation by
    Universities/InstitutesIdiopathic Pulmonary
    Fibrosis - Pipeline Products GlanceLate Stage
    ProductsClinical Stage ProductsEarly Stage
    Products

www.aarkstore.com
6
List Of Tables
  • Number of Products under Development for
    Idiopathic Pulmonary Fibrosis, H2 2014Number of
    Products under Development for Idiopathic
    Pulmonary Fibrosis - Comparative Analysis, H2
    2014Number of Products under Development by
    Companies, H2 2014Number of Products under
    Development by Companies, H2 2014
    (Contd..1)Number of Products under Development
    by Companies, H2 2014 (Contd..2)Number of
    Products under Investigation by
    Universities/Institutes, H2 2014Comparative
    Analysis by Late Stage Development, H2
    2014Comparative Analysis by Clinical Stage
    Development, H2 2014Comparative Analysis by
    Early Stage Development, H2 2014Products under
    Development by Companies, H2 2014

www.aarkstore.com
7
List Of Figures
  • Number of Products under Development for
    Idiopathic Pulmonary Fibrosis, H2 2014Number of
    Products under Development for Idiopathic
    Pulmonary Fibrosis - Comparative Analysis, H2
    2014Number of Products under Development by
    Companies, H2 2014Number of Products under
    Investigation by Universities/Institutes, H2
    2014Comparative Analysis by Clinical Stage
    Development, H2 2014Comparative Analysis by
    Early Stage Products, H2 2014Assessment by
    Monotherapy Products, H2 2014Number of Products
    by Top 10 Target, H2 2014Number of Products by
    Stage and Top 10 Target, H2 2014Number of
    Products by Top 10 Mechanism of Action, H2 2014

www.aarkstore.com
8
Related Market Research reports
  • Corticosteroid-Responsive Dermatoses - Pipeline
    Review, H1 2014
  • Hematological Tumor - Pipeline Review, H1 2014
  • Inflammation - Pipeline Review, H1 2014
  • Opioid Induced Side Effects - Pipeline Review, H1
    2014
  • Skin Infections - Pipeline Review, H1 2014

www.aarkstore.com
9
Related Market Research reports
  • Restenosis - Pipeline Review, H1 2014
  • Tauopathies - Pipeline Review, H1 2014
  • Nasopharyngitis (Common Cold) - Pipeline Review,
    H1 2014
  • Mucopolysaccharidosis III (MPS III) (Sanfilippo
    Syndrome) - Pipeline Review, H1 2014
  • Chemotherapy Induced Peripheral Neuropathy -
    Pipeline Review, H1 2014

www.aarkstore.com
10
Aarkstore - Idiopathic Pulmonary Fibrosis -
Pipeline Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog http//www.aarkstore.com/blog/
  • Conference http//conference.aarkstore.com/
  • News http//www.aarkstore.com/news

www.aarkstore.com
About PowerShow.com